The smart home device developer has closed an American Family Ventures-backed round that lifted its overall funding to at least $35m.

Axa Investment Managers was among the participants in a $13.9m round for Alydia, which is developing a system to treat postpartum haemorrhage.

You and Mr Jones returned in a series B round for AI Foundation, developer of a detection system for manipulated online content.

GE Ventures has divested stakes in 16 companies including Carbon, Desktop Metal and Proterra to venture firm 40 North Ventures.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

There are occasional silver linings even for the blackest clouds. One was as the Covid-19 disease broke out this year competition for deals became a little lighter.

Omega Therapeutics is firing up preclinical development of an epigenomic drug platform invented at Whitehead Institute and incubated by Flagship Pioneering.

Nura Bio is working on neuroprotective treatments that exploit discoveries made at OHSU and UT Southwestern.

Cerevel Therapeutics, co-founded by Pfizer, is set to undertake a reverse merger with Nasdaq-listed Arya II in a deal that will give Cerevel a market cap of $1.3bn.

The fund will invest in companies developing products and services within the cryptocurrency exchange’s ecosystem.